Patrick Donnelly

Mr. Donnelly, who has more than 35 years of experience, was most recently Chairman and Chief Executive Officer of Aptiv Solutions, a global pharmaceutical development services business he founded which sold to ICON (NASDAQ:ICLR) in May 2014. Prior to this, Pat served as President, Chief Executive Officer, and was one of the founders of PRA International (now PRA Health Sciences, NASDAQ:PRAH). He was instrumental in building PRA over twelve years from a small regional contract research organization to a global leader in the industry. Mr. Donnelly received his M.B.A. from Pennsylvania State University in 1984 and received his BS from the University of Missouri in 1980.

Pat currently serves as a board director for Linden portfolio companies, ProPharma Group and Advarra.  Pat is also a board director at MedGenesis Therapeutix, Phase 5 LLC, and Rediscovery Life Sciences.

Company Blog

May 14, 2018
The Power to See Differences that Matter
What are the real-world consequences of giving inadequate consideration to power when developing a… Read More
April 24, 2018
ProPharma Group Announces New President / CEO
ProPharma Group announces today that Dawn Sherman will be joining the company as President… Read More
April 3, 2018
Understanding the New Combination Product PMSR Guidance Documents and Impact…
Take a closer look at new FDA guidance documents surrounding postmarketing safety reporting (PMSR)… Read More
More Articles

UPCOMING Events

June 04, 2018
BIO International
The BIO International Convention  attracts more than 16,000 biotechnology and pharma leaders who come togethe... Read More
June 05, 2018
DIA Pharmacovigilance Conference
Join the DIA Pharmacovigilance Conference to discuss the current landscape and join intense and well-lead dis... Read More
June 24, 2018
DIA Annual 2018
The DIA 2018 Global Annual Meeting brings together thousands of innovators from around the globe. Designed to ... Read More
All Events
Contact Us